e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prognostic significance of 6-minute walk test in non-group 1 pulmonary hypertension
R. Golpe, O. Castro-Añón, L. A. Pérez de Llano, C. González-Juanatey, M. C. Muñiz-Fernández, A. Testa-Fernández, R. Pérez-Fernández (Lugo, Spain)
Source:
Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Session:
Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Session type:
Thematic Poster Session
Number:
2611
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Golpe, O. Castro-Añón, L. A. Pérez de Llano, C. González-Juanatey, M. C. Muñiz-Fernández, A. Testa-Fernández, R. Pérez-Fernández (Lugo, Spain). Prognostic significance of 6-minute walk test in non-group 1 pulmonary hypertension. Eur Respir J 2013; 42: Suppl. 57, 2611
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Patient with ankylosing spondylitis and pulmonary hypertension
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Related content which might interest you:
Relationship between sit-to-stand test and six-minute walk test in patients with pulmonary arterial hypertension
Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods
Year: 2015
Prognostic impact of oxygen saturation during the 6-minute walk test in pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Comparability of shuttle walk test with 6-minutes walk test in pulmonary diseases with emphasis on pulmonary arterial hypertension
Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Year: 2013
Physiological response to the six-minute walk test in pulmonary arterial hypertension
Source: Eur Respir J 2005; 26: 667-672
Year: 2005
Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension
Source: Eur Respir J 2012; 40: 1410-1419
Year: 2012
Exercise capacity in chronic obstructive pulmonary disease: Cardiopulmonary exercise testing versus 6-minute walk test
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019
Blood pressure variability during the 6-minute walk test in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Clinical predictors of pulmonary hypertension in sarcoidosis
Source: Eur Respir J 2008; 32: 296-302
Year: 2008
Safety related to maximal cardiopulmonary exercise testing in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Clinical determinants of six-minute walking test in pulmonary sarcoidosis
Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside
Year: 2010
Stops and its correlation with new measurements during the six-minute walk test in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Clinical exercise physiology in health and disease
Year: 2016
The six-minute walking test accompanied by pulse oximetry and ventilation assessment in patients with pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013
Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension
Source: Eur Respir J 2006; 27: 114-120
Year: 2006
Six-minute walk test correlates with hemodynamic severity in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 111s
Year: 2004
Exercise testing in pulmonary hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017
Exercise testing in pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014
Exercise testing in pulmonary hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012
Exercise testing in pulmonary hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept